P
eyronie's disease (PD) is a debilitating sexual condition characterised by penile pain, curvature and/or deformity (Figure 1 ), palpable plaque and erectile dysfunction (ED). 1 While no one truly knows the underlying pathophysiology of PD, it is generally agreed that it is considered an aberrant wound-healing disorder and that the development of PD is a result of repetitive trauma to the erect penis with ensuing fibrous plaque formation within the bilayer of tunica albuginae among genetically susceptible individuals. 1 Studies have shown that PD occurs in up to 9% of adult men and it is often difficult to predict the natural history, with up to 48% of cases progressing if left untreated. 2 PD often results in increased risk of depression, low self-esteem and relationship difficulties, and affects both the man's and his partner's quality of life. 1, 3 The PD process can be divided into two main phases: acute (inflammatory) and chronic (stable) stages. In the acute stage, the patient usually describes a short duration (less than 6 months), penile pain, or changing penile curvature and/or deformity. 4 The chronic phase of PD is characterised by the presence of penile plaque, a complex deformity such as hinge or hourglass deformity and ED. The majority of penile plaque occurs on the dorsal aspect, giving rise to dorsal penile curvature, 5 and in advanced cases the plaque can become ossified causing considerable penile shortening.
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DIAGNOSIS OF PD
The diagnosis of PD is usually evident on clinical history, penile examination and digital photographs. The history should specifically address time of onset, pain, deformity, palpable penile lesion, preceding trauma, previous therapy and presence of ED. The presence of ED is not uncommon among men with PD. At present, a PD questionnaire is not used commonly outside of research even though it has been validated. 6 The assessment of ED can be made using the validated International Index of Erectile Function-5 questionnaire. On examination, the penis should be stretched fully to assess the penile length and to palpate underlying penile plaque. Digital photographs and penile examination with the aid of vasoactive intracavernosal injection are useful to document the extent of PD, vascular integrity and erectile response. The use of penile duplex ultrasonography often aids the diagnosis and provides additional prognostic information. 7 Patients with isolated septal scar often complain of loss of penile length, while those with intracavernosal fibrosis have difficulty maintaining an erection. Furthermore, larger plaque size and impaired cavernosal arterial flow diagnosed on penile colour duplex scan correlate strongly with ED. 8 
TREATMENT OF PD
Among the greatest challenges facing clinicians treating patients with PD is the lack of a defined treatment protocol and rehabilitative strategies, and often the treatment pathways are dictated based on physician intuition. 1 Increasing knowledge concerning the molecular basis of PD is evolving as a result of important new innovative basic science research studies, 9 and growing volumes of literature on various therapeutic options in PD have now allowed clinicians to educate and counsel patients on various treatment options ( Figure 2 and Table 1 ). 1 The current therapy for PD can be divided into three groups: namely, medical therapy, minimally invasive therapy and surgery. Patients should be counselled on the benefits and risks of each individual treatment. 10 and low-dose tadalafil 11 in PD.
MEDICAL THERAPY
Intralesional injectables
Intralesional injections are suitable in younger men with acute phase of ED, small clinical palpable, non-ossified plaque disease and mild/moderate penile curvature. 12 Of the injectable agents in PD, verapamil, interferon alpha 2B and collagenase are shown to be effective in placebo-controlled trials. The disadvantages to intralesional injections are penile pain and bruise, the need for a repetitive treatment cycle, and efficacy of less than 50%. 13 More recently it has been reported that combination therapies using oral therapy, intralesional injections and penile traction therapy may have additional benefits compared with single therapy. 14 
Topical therapies
The use of low-intensity shockwave therapy has been explored in the past and recent advances in this technology have stimulated renewed interest. Unfortunately, published literature on the efficacy of lowintensity shockwave therapy on PD-related deformity has not been strong. 1 Iontophoresis or transdermal electromotive administration of dexamethasone, verapamil and lidocaine may be effective in terms of reduction of pain, plaque size and curvature, but further studies are required to evaluate fully the role of iontophoresis as a treatment modality in PD. 1 The role of penile traction therapy in PD has gained considerable interest lately and current published literature suggests that traction therapy is effective in increasing penile length and reducing the penile deformity as well as possibly penile pain. 15 The ideal candidate is a patient with acutephase PD and short penis, large penile curvature with no calcified penile plaque or complex penile deformity and normal erectile function. However, the patient needs to be highly motivated and compliant with use of a traction device for a minimum of 4-6 hours per day for at least 3-6 months in order to gain maximal benefit.
SURGICAL INTERVENTIONS
Surgery is indicated in men who have failed conservative measures and/or have stable PD (ie history longer than 6 months with no pain and stable deformity). In addition, patients who have extensive plaque calcification and those who want the quickest and most reliable outcome should consider surgery. 16 It is important to provide adequate preoperative counselling to set the patient's expectation, as surgery is associated with the risks of loss of penile length, persistent or recurrent curvature, ED and altered penile sensation postoperatively. The severity of penile deformity and underlying erectile function are two key preoperative factors that determine the choice and success of surgery.
Penile plication
Penile plication procedures such as the Nesbitt procedure, the Yachia technique and Lue's 16-dot procedure are designed to shorten the longer side of the penis to compensate for the contralateral curvature. The advantages of plication surgery are that it is often simple, minimally invasive and likely to preserve underlying erectile function. The disadvantages are that it invariably shortens the penis, it is less effective when the penile curvature is greater than 60 degrees, and it will not correct any hourglass or hinge penile deformity.
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Peyronie's graft Graft surgery can be performed with plaque incision or partial excision. While the ideal graft material remains elusive, various autologous tissue dermis, vein or tunical, and allograft and xenograft materials such as pericardium, small intestinal submucosa and dermis, have been used and have shown satisfactory postoperative outcome. The advantages of graft surgery are that it is effective in treating larger penile curvature and complex penile deformity and to a certain extent it preserves the penile length postoperatively. However, graft surgery can affect the underlying veno-occlusive mechanism, resulting in decreased penile rigidity postoperatively. 17 Postoperative penile care is advisable and often involves penile massage and stretch therapy, the use of oral phosphodiesterase type 5 inhibitors and/or use of an external penile traction device. 
Penile prosthesis implant
A penile prosthesis implant with straightening manoeuvres (eg penile remodelling) is indicated in men who have poor erectile function and/or medically refractory ED. While prosthesis implant alone is often enough to straighten a small penile curvature, those with residual curvature greater than 30 degrees may need manual modelling and other adjunctive manoeuvres. 18 The use of graft material placed over the prosthesis may be required in large and complex penile curvature but may increase the risk of infection.
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FUTURE DIRECTIONS
While the current therapies address the penile curvature, they are not very effective in treating penile pain and preventing recurrent penile curvature in the future. It is likely that the use of antifibrogenic and fibrinolytic agents such as transforming growth factor beta type 1 receptor inhibitors, phosphodiesterase type 5 inhibitors and matrix metalloproteinases may represent a novel targeted approach to treating PD in the future. 19 The increased knowledge and utility of translational research has resulted in the use of stem cells to prevent fibrosis and restore erectile function in the animal model of PD 20 and may one day be applicable in the human.
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